[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.191.72. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 28, 1962

American Drug Index, 1962

JAMA. 1962;181(4):355. doi:10.1001/jama.1962.03050300075033

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

Two texts, in this reviewer's opinion, are outstanding in the presentation of nomenclature information in the drug field. They are not mutually exclusive. One is the subject of this review; the other is the Merck Index.

The American Drug Index, by virtue of its more frequent publication schedule, provides more nomenclature information on newer drug products. It identifies these products in terms of all designations ( nonproprietary names and trademarks) that have been brought into use. While not, as yet, fully implemented, a significant feature of the present edition is the identification of those nonproprietary names adopted as a result of formal processes ( USP, NF, or AMA, the latter covering names adopted by the AMA Nomenclature Committee or its successor the AMA-USP Nomenclature Committee).

The American Drug Index presents, in well-organized fashion, adequate information to permit identification of the listed drug products in terms of other existing names, manufacturer, and therapeutic

First Page Preview View Large
First page PDF preview
First page PDF preview
×